Cargando…

The HSP90 Inhibitor, AUY-922, Protects and Repairs Human Lung Microvascular Endothelial Cells from Hydrochloric Acid-Induced Endothelial Barrier Dysfunction

Exposure to hydrochloric acid (HCl) leads acutely to asthma-like symptoms, acute respiratory distress syndrome (ARDS), including compromised alveolo-capillary barrier, and respiratory failure. To better understand the direct effects of HCl on pulmonary endothelial function, we studied the characteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Colunga Biancatelli, Ruben M. L., Solopov, Pavel, Gregory, Betsy, Catravas, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232030/
https://www.ncbi.nlm.nih.gov/pubmed/34199261
http://dx.doi.org/10.3390/cells10061489
_version_ 1783713551217590272
author Colunga Biancatelli, Ruben M. L.
Solopov, Pavel
Gregory, Betsy
Catravas, John D.
author_facet Colunga Biancatelli, Ruben M. L.
Solopov, Pavel
Gregory, Betsy
Catravas, John D.
author_sort Colunga Biancatelli, Ruben M. L.
collection PubMed
description Exposure to hydrochloric acid (HCl) leads acutely to asthma-like symptoms, acute respiratory distress syndrome (ARDS), including compromised alveolo-capillary barrier, and respiratory failure. To better understand the direct effects of HCl on pulmonary endothelial function, we studied the characteristics of HCl-induced endothelial barrier dysfunction in primary cultures of human lung microvascular endothelial cells (HLMVEC), defined the involved molecular pathways, and tested the potentially beneficial effects of Heat Shock Protein 90 (HSP90) inhibitors. HCl impaired barrier function in a time- and concentration-dependent manner and was associated with activation of Protein Kinase B (AKT), Ras homolog family member A (RhoA) and myosin light chain 2 (MLC2), as well as loss of plasmalemmal VE-cadherin, rearrangement of cortical actin, and appearance of inter-endothelial gaps. Pre-treatment or post-treatment of HLMVEC with AUY-922, a third-generation HSP90 inhibitor, prevented and restored HCl-induced endothelial barrier dysfunction. AUY-922 increased the expression of HSP70 and inhibited the activation (phosphorylation) of extracellular-signal regulated kinase (ERK) and AKT. AUY-922 also prevented the HCl-induced activation of RhoA and MLC2 and the internalization of plasmalemmal VE-cadherin. We conclude that, by increasing the expression of cytoprotective proteins, interfering with actomyosin contractility, and enhancing the expression of junction proteins, inhibition of HSP90 may represent a useful approach for the management of HCl-induced endothelial dysfunction and acute lung injury.
format Online
Article
Text
id pubmed-8232030
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82320302021-06-26 The HSP90 Inhibitor, AUY-922, Protects and Repairs Human Lung Microvascular Endothelial Cells from Hydrochloric Acid-Induced Endothelial Barrier Dysfunction Colunga Biancatelli, Ruben M. L. Solopov, Pavel Gregory, Betsy Catravas, John D. Cells Article Exposure to hydrochloric acid (HCl) leads acutely to asthma-like symptoms, acute respiratory distress syndrome (ARDS), including compromised alveolo-capillary barrier, and respiratory failure. To better understand the direct effects of HCl on pulmonary endothelial function, we studied the characteristics of HCl-induced endothelial barrier dysfunction in primary cultures of human lung microvascular endothelial cells (HLMVEC), defined the involved molecular pathways, and tested the potentially beneficial effects of Heat Shock Protein 90 (HSP90) inhibitors. HCl impaired barrier function in a time- and concentration-dependent manner and was associated with activation of Protein Kinase B (AKT), Ras homolog family member A (RhoA) and myosin light chain 2 (MLC2), as well as loss of plasmalemmal VE-cadherin, rearrangement of cortical actin, and appearance of inter-endothelial gaps. Pre-treatment or post-treatment of HLMVEC with AUY-922, a third-generation HSP90 inhibitor, prevented and restored HCl-induced endothelial barrier dysfunction. AUY-922 increased the expression of HSP70 and inhibited the activation (phosphorylation) of extracellular-signal regulated kinase (ERK) and AKT. AUY-922 also prevented the HCl-induced activation of RhoA and MLC2 and the internalization of plasmalemmal VE-cadherin. We conclude that, by increasing the expression of cytoprotective proteins, interfering with actomyosin contractility, and enhancing the expression of junction proteins, inhibition of HSP90 may represent a useful approach for the management of HCl-induced endothelial dysfunction and acute lung injury. MDPI 2021-06-13 /pmc/articles/PMC8232030/ /pubmed/34199261 http://dx.doi.org/10.3390/cells10061489 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Colunga Biancatelli, Ruben M. L.
Solopov, Pavel
Gregory, Betsy
Catravas, John D.
The HSP90 Inhibitor, AUY-922, Protects and Repairs Human Lung Microvascular Endothelial Cells from Hydrochloric Acid-Induced Endothelial Barrier Dysfunction
title The HSP90 Inhibitor, AUY-922, Protects and Repairs Human Lung Microvascular Endothelial Cells from Hydrochloric Acid-Induced Endothelial Barrier Dysfunction
title_full The HSP90 Inhibitor, AUY-922, Protects and Repairs Human Lung Microvascular Endothelial Cells from Hydrochloric Acid-Induced Endothelial Barrier Dysfunction
title_fullStr The HSP90 Inhibitor, AUY-922, Protects and Repairs Human Lung Microvascular Endothelial Cells from Hydrochloric Acid-Induced Endothelial Barrier Dysfunction
title_full_unstemmed The HSP90 Inhibitor, AUY-922, Protects and Repairs Human Lung Microvascular Endothelial Cells from Hydrochloric Acid-Induced Endothelial Barrier Dysfunction
title_short The HSP90 Inhibitor, AUY-922, Protects and Repairs Human Lung Microvascular Endothelial Cells from Hydrochloric Acid-Induced Endothelial Barrier Dysfunction
title_sort hsp90 inhibitor, auy-922, protects and repairs human lung microvascular endothelial cells from hydrochloric acid-induced endothelial barrier dysfunction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232030/
https://www.ncbi.nlm.nih.gov/pubmed/34199261
http://dx.doi.org/10.3390/cells10061489
work_keys_str_mv AT colungabiancatellirubenml thehsp90inhibitorauy922protectsandrepairshumanlungmicrovascularendothelialcellsfromhydrochloricacidinducedendothelialbarrierdysfunction
AT solopovpavel thehsp90inhibitorauy922protectsandrepairshumanlungmicrovascularendothelialcellsfromhydrochloricacidinducedendothelialbarrierdysfunction
AT gregorybetsy thehsp90inhibitorauy922protectsandrepairshumanlungmicrovascularendothelialcellsfromhydrochloricacidinducedendothelialbarrierdysfunction
AT catravasjohnd thehsp90inhibitorauy922protectsandrepairshumanlungmicrovascularendothelialcellsfromhydrochloricacidinducedendothelialbarrierdysfunction
AT colungabiancatellirubenml hsp90inhibitorauy922protectsandrepairshumanlungmicrovascularendothelialcellsfromhydrochloricacidinducedendothelialbarrierdysfunction
AT solopovpavel hsp90inhibitorauy922protectsandrepairshumanlungmicrovascularendothelialcellsfromhydrochloricacidinducedendothelialbarrierdysfunction
AT gregorybetsy hsp90inhibitorauy922protectsandrepairshumanlungmicrovascularendothelialcellsfromhydrochloricacidinducedendothelialbarrierdysfunction
AT catravasjohnd hsp90inhibitorauy922protectsandrepairshumanlungmicrovascularendothelialcellsfromhydrochloricacidinducedendothelialbarrierdysfunction